Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:administeredBy |
injection
|
| gptkbp:approvalYear |
1990
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
L03AX05
|
| gptkbp:contains |
gptkb:pegademase
|
| gptkbp:discontinued |
2023
|
| gptkbp:genericName |
gptkb:pegademase_bovine
|
| https://www.w3.org/2000/01/rdf-schema#label |
Adagen
|
| gptkbp:manufacturer |
gptkb:Leadiant_Biosciences
|
| gptkbp:mechanismOfAction |
enzyme replacement therapy
|
| gptkbp:routeOfAdministration |
intramuscular
|
| gptkbp:status |
orphan drug
|
| gptkbp:treatment |
adenosine deaminase deficiency
|
| gptkbp:usedFor |
severe combined immunodeficiency disease
|
| gptkbp:bfsParent |
gptkb:Enzon_Pharmaceuticals
|
| gptkbp:bfsLayer |
7
|